Better Buy: Ocugen or Novavax? | The Motley Fool
Will either of these hopeful vaccine makers continue to thrash the market?
Source: fool.com
Page 3 - Patrick Bafuma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Bafuma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Bafuma Today - Breaking & Trending Today
Ocugen Stock: Bull vs. Bear | The Motley Fool
There's more to this potential coronavirus vaccine stock than what happens in the next 12 months.
Source: fool.com
Better Buy: Vertex Pharmaceuticals vs. CRISPR
The companies are collaborating on a potential blockbuster.
Source: fool.com
3 Under-the-Radar COVID Stocks | The Motley Fool
Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.
Source: fool.com
3 COVID Stocks That Can Turn $1,000 Into $10,000
Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic.
Source: fool.com